Navigation Links
MRI Detects Cancers in the Opposite Breast of Women Newly Diagnosed,with Breast Cancer

PHILADELPHIA, March 28, 2007 /PRNewswire-USNewswire/ -- Magnetic Resonance Imaging (MRI) scans of women who were diagnosed with cancer in one breast detected over 90 percent of cancers in the other breast that were missed by mammography and clinical breast exam at initial diagnosis, according to a new study. Given the established rates of mammography and clinical breast exams for detecting cancer in the opposite, or contralateral breast, adding an MRI scan to the diagnostic evaluation effectively doubled the number of cancers immediately found in these women. The of Radiology Imaging Network (ACRIN) study, supported by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), appears in the March 29, 2007 issue of the "New England Journal of Medicine"*.

"One in ten women diagnosed with cancer in one breast will develop the disease in the opposite breast. Having a better technique to find these cancers as early as possible will increase the chances of successful treatment," said NIH Director Elias A. Zerhouni, M.D.

The ACRIN trial was designed to determine whether the use of MRI could improve upon clinical breast exam and mammography in detecting breast cancer in the opposite breast at the time of the initial breast cancer diagnosis. The study recruited 1,007 women from 25 institutions who had a recent diagnosis of cancer in one breast. Of these, 969 women completed the study, which began in April 2003. All of the women enrolled had a negative mammogram and negative clinical breast exam of the opposite breast within 90 days prior to the MRI. After receiving an MRI, 33 contralateral breast cancers were diagnosed in the study. Thirty of these tumors, or 91 percent, were diagnosed as a result of MRI. The other three cancers were detected due to subsequent mastectomies. Researchers found that the added benefit of MRI was consistent, regardless of a woman's cancer type, age,
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
2. Publication Confirms that EpCAM, the Target for Two of Micromets Product Candidates, Is Overexpressed on Cancer Stem Cells of Certain Cancers
3. Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO
4. Poniard Pharmaceuticals Announces Promising Data From Interim Safety Analysis of Phase 1 Combination Trials of Picoplatin in Colorectal and Prostate Cancers
5. Human Genome Sciences Reports Growing Evidence That Its TRAIL Receptor Antibodies Have Significant Potential in the Treatment of a Broad Range of Cancers
6. EntreMed Presents Preclinical Data for MKC-1 in Hematological Cancers
7. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
8. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
9. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
10. Mayo Clinic News Release: Mayo Clinic-led Study Improves Breast Cancer Risk Prediction in Women with Atypia
11. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer

Post Your Comments:
(Date:11/24/2009)...ia/--ChindexInternational,Inc.,("Chindex")(Nasdaq:...rn,healthcareproductsandservicesinthePeople,sRepub...the21stAnnualPiperJaffray,"Unplugged"HealthCareCon...ceHotel. , Managementiscurrentlyscheduledtopr...ne-on-onemeetingsthroughouttheday.Awebcast,ofthepr...
(Date:11/24/2009)...FirstCall/--Vermillion,Inc.(VRML)(PinkSheets:VRMLQ...dDisclosureStatementtoday,November24,2009,withtheU....AhearingtoconsiderapprovaloftheDisclosureStatemen...ingontheconfirmationofthePlanscheduledforJanuary7,...sinfull.ThePlanisexpected,ifapproved,toallowholder...
(Date:11/24/2009)...re-FirstCall/--ThoratecCorporation(Nasdaq: THOR ),...porttherapiestosave,supportandrestorefailinghearts...PiperJaffrayHealthCareConferenceonTuesday,December...effinancialofficer,willprovideanupdateonthecompany...PacificStandardTime). ,, Thepresentationwillbea...
Breaking Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Brown 26amp 3B Toland Supports Fight Against Hepatitis B 60447 1Brown 26amp 3B Toland Supports Fight Against Hepatitis B 60447 2NAMI Applauds Initial Review of The Affordable Health Care of America Act and Health Care Reform 60444 1NAMI Applauds Initial Review of The Affordable Health Care of America Act and Health Care Reform 60444 2NAMI Applauds Initial Review of The Affordable Health Care of America Act and Health Care Reform 60444 3Metropolitan Chicago Breast Cancer Task Force Announced Members of Chicago Breast Cancer Quality Consortium 60440 1Metropolitan Chicago Breast Cancer Task Force Announced Members of Chicago Breast Cancer Quality Consortium 60440 2Metropolitan Chicago Breast Cancer Task Force Announced Members of Chicago Breast Cancer Quality Consortium 60440 3Metropolitan Chicago Breast Cancer Task Force Announced Members of Chicago Breast Cancer Quality Consortium 60440 4Metropolitan Chicago Breast Cancer Task Force Announced Members of Chicago Breast Cancer Quality Consortium 60440 5
... Myeloma Workshop held in,Kos, Greece demonstrates...th bortezomib, dexamethasone and lenalidomide plus...ry multiple,myeloma, and as a single agent in pati...lobulinemia, NEW YORK, June 29, 2007 /PRNewswire-F...announced that 4 posters were,presented at the 11t...
... vaccine has shown 90%,efficacy for prevention of ...d with the human papillomavirus (HPV) types target...published early Online,and in the upcoming issue o... or more,cases of cervical cancer worldwide, but t...ntribute to cervical cancer. , Professor Jorma Paa...
Other Medicine Technology:Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 2Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 3Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 4Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 5Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 6Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 7Vaccine Can Prevent Cervical Cancer and Precancerous Lesions 2
(Date:11/26/2009)... , Benton Communications ...siness growth system for retailers struggling to m... (PRWEB) November 26, 2009 -- Flu fears is the t...les to the emergency room, according to Dr. David ...ewly released business growth system – The ...
(Date:11/25/2009)... ,, TORONTOandCALGARY,Nov.25/PRNewswire/-Sen...esonanceImaging(MRI)coilsandsoftwareandCalgaryScie...ologies,haveintroducedawebversionofAegis(TM)Breast...iveinterfaceisthefirsttrulyzero-footprintWebclient...ntific,sPureWeb(TM)platformallowsforzero-footprint...
(Date:11/25/2009)... ,, SANFRANCISCO,Nov.25/PRNewswire/--TheBayA...sfirst Winter Spare the Air Alert fo...facturedfirelogsoranyothersolidfuel,bothindoorsand...unhealthyairqualitytomorrow,"saidJackBroadbent,exe...esidentstorespectthehealthoftheirneighborsandfello...
(Date:11/25/2009)... , Does stress increase blood pressure? This sim...h for many years. New Stress-related gene Modulat... increase blood pressure? This simple question ha...s. Now new research has for the first time establ...the blood pressure response to stress in mice as w...
(Date:11/25/2009)... Survivors often plagued by neurological symptoms...ealthDay News) -- Neurological side effects are am...ivors of testicular cancer who were treated with c.... , The study included 1,409 Norwegian men trea...and 1994 who took part in a follow-up survey condu...
Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:New stress-related gene modulates high blood pressure in mice and men 2
...day,announced the first true single port laparosco...tem., At Baystate Medical Center, Springfield, MA...Surgery, performed a gallbladder removal procedure...eals. This provides unobstructed access to the cav...
...n and Adults With Dis...ream Corporation,today announced results of its 27...ser to benefit Easter Seals. Since the conclusion ...se dollars,were raised during the chain-wide ,Cone...
...y,(NYSE: LLY ) today announced that the European ...EO(R) (teriparatide [rDNA origin] injection) for t...ined, systemic,glucocorticoid therapy in women and... Human Use (CHMP) of the European,Medicines Evalua...
...ording Artist Chaka Khan, LOS ANGELES, April 3, 2...millionth visitor to BODY WORLDS today. This marks...eaking run for BODY WORLDS,at the California Scien...onsored by her foundation, were at the,exhibit whe...
...er the incidents , , THURSDAY, April 3 (He...tner violence suffer a wide range of physical and ...zation study that included 25,000 women in 11 coun...d Republic of Tanzania.,The study found that havin...
... to join Harvard University,s Ash Institute for De... the bi-annual conference,Frontiers of Innovation:...ridge March 31st through today. On Monday evening,... neglected,diseases and in disaster preparedness i...
Other Medicine News:Health News:SurgiQuest Announces First Procedure Using AirSeal(TM) Access System 2Health News:Friendly's Dishes Out $616,000 for Easter Seals 2Health News:FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis 2Health News:FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis 3Health News:FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis 4Health News:FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis 5Health News:California Science Center Welcomes 1-Millionth BODY WORLDS Visitor 2Health News:Male Partner Violence Hurts Women's Health Worldwide 2Health News:PAHEF Discusses Neglected Diseases and Disaster Preparedness with Innovative Leaders 2
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
Medicine Products: